Display options
Share it on

JAMA Netw Open. 2019 Nov 01;2(11):e1916318. doi: 10.1001/jamanetworkopen.2019.16318.

Association Between Marijuana Use and Risk of Cancer: A Systematic Review and Meta-analysis.

JAMA network open

Mehrnaz Ghasemiesfe, Brooke Barrow, Samuel Leonard, Salomeh Keyhani, Deborah Korenstein

Affiliations

  1. Northern California Institute of Research and Education, San Francisco.
  2. San Francisco Veterans Affairs Medical Center, San Francisco, California.
  3. Currently a medical student at Warren Alpert Medical School of Brown University, Providence, Rhode Island.
  4. Department of Medicine, University of California, San Francisco.
  5. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  6. Weill Cornell Medical College, New York, New York.

PMID: 31774524 PMCID: PMC6902836 DOI: 10.1001/jamanetworkopen.2019.16318

Abstract

IMPORTANCE: Marijuana use is common and growing in the United States amid a trend toward legalization. Exposure to tobacco smoke is a well-described preventable cause of many cancers; the association of marijuana use with the development of cancer is not clear.

OBJECTIVE: To assess the association of marijuana use with cancer development.

DATA SOURCES: A search of PubMed, Embase, PsycINFO, MEDLINE, and the Cochrane Library was conducted on June 11, 2018, and updated on April 30, 2019. A systematic review and meta-analysis of studies published from January 1, 1973, to April 30, 2019, and references of included studies were performed, with data analyzed from January 2 through October 4, 2019.

STUDY SELECTION: English-language studies involving adult marijuana users and reporting cancer development. The search strategy contained the following 2 concepts linked together with the AND operator: marijuana OR marihuana OR tetrahydrocannabinol OR cannabinoid OR cannabis; AND cancer OR malignancy OR carcinoma OR tumor OR neoplasm.

DATA EXTRACTION AND SYNTHESIS: Two reviewers independently reviewed titles, abstracts, and full-text articles; 3 reviewers independently assessed study characteristics and graded evidence strength by consensus.

MAIN OUTCOMES AND MEASURES: Rates of cancer in marijuana users, with ever use defined as at least 1 joint-year exposure (equivalent to 1 joint per day for 1 year), compared with nonusers. Meta-analysis was conducted if there were at least 2 studies of the same design addressing the same cancer without high risk of bias when heterogeneity was low to moderate for the following 4 cancers: lung, head and neck squamous cell carcinoma, oral squamous cell carcinoma, and testicular germ cell tumor (TGCT), with comparisons expressed as odds ratios (ORs) with 95% CIs.

RESULTS: Twenty-five English-language studies (19 case-control, 5 cohort, and 1 cross-sectional) were included; few studies (n = 2) were at low risk of bias. In pooled analysis of case-control studies, ever use of marijuana was not associated with head and neck squamous cell carcinoma or oral cancer. In pooled analysis of 3 case-control studies, more than 10 years of marijuana use (joint-years not reported) was associated with TGCT (OR, 1.36; 95% CI, 1.03-1.81; P = .03; I2 = 0%) and nonseminoma TGCT (OR, 1.85; 95% CI, 1.10-3.11; P = .04; I2 = 0%). Evaluations of ever use generally found no association with cancers, but exposure levels were low and poorly defined. Findings for lung cancer were mixed, confounded by few marijuana-only smokers, poor exposure assessment, and inadequate adjustment; meta-analysis was not performed for several outcomes.

CONCLUSIONS AND RELEVANCE: Low-strength evidence suggests that smoking marijuana is associated with developing TGCT; its association with other cancers and the consequences of higher levels of use are unclear. Long-term studies in marijuana-only smokers would improve understanding of marijuana's association with lung, oral, and other cancers.

TRIAL REGISTRATION: PROSPERO identifier: CRD42018102457.

References

  1. Cancer Res. 2004 Jun 1;64(11):4049-54 - PubMed
  2. Am J Epidemiol. 1999 Aug 15;150(4):375-89 - PubMed
  3. Eur J Intern Med. 2018 Mar;49:2-6 - PubMed
  4. J Thorac Oncol. 2008 Dec;3(12):1398-403 - PubMed
  5. Ann N Y Acad Sci. 1976;282:405-15 - PubMed
  6. Cancer Med. 2018 Mar;7(3):765-775 - PubMed
  7. N Engl J Med. 1988 Feb 11;318(6):347-51 - PubMed
  8. Drug Alcohol Depend. 2017 Aug 1;177:299-306 - PubMed
  9. BMJ. 2003 Sep 6;327(7414):557-60 - PubMed
  10. Ann Epidemiol. 2010 Apr;20(4):289-97 - PubMed
  11. Int J Cancer. 2015 Feb 15;136(4):894-903 - PubMed
  12. Am J Public Health. 1987 Apr;77(4):425-31 - PubMed
  13. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1829-34 - PubMed
  14. Andrology. 2019 Mar;7(2):139-147 - PubMed
  15. Chem Res Toxicol. 2008 Feb;21(2):494-502 - PubMed
  16. Ann Intern Med. 2009 Aug 18;151(4):264-9, W64 - PubMed
  17. Carcinogenesis. 1997 Jul;18(7):1359-63 - PubMed
  18. AIDS Res Hum Retroviruses. 2009 Feb;25(2):149-56 - PubMed
  19. Cancer. 1992 Jul 1;70(1):69-76 - PubMed
  20. Can Urol Assoc J. 2017 Mar-Apr;11(3-4):E138-E142 - PubMed
  21. Arch Oral Biol. 2015 Dec;60(12):1750-5 - PubMed
  22. Cureus. 2019 Jan 19;11(1):e3918 - PubMed
  23. Cancer. 2011 Feb 15;117(4):848-53 - PubMed
  24. Respir Care. 2016 Nov;61(11):1543-1551 - PubMed
  25. Chest. 1997 Aug;112(2):319-26 - PubMed
  26. Oral Oncol. 2004 Mar;40(3):304-13 - PubMed
  27. Otolaryngol Head Neck Surg. 2008 Mar;138(3):374-80 - PubMed
  28. J Natl Cancer Inst. 2008 Mar 19;100(6):407-20 - PubMed
  29. Arch Intern Med. 2006 Jul 10;166(13):1359-67 - PubMed
  30. Addiction. 2015 Nov;110(11):1699-704 - PubMed
  31. J Neurooncol. 2004 May;68(1):57-69 - PubMed
  32. JAMA Pediatr. 2018 Nov 1;172(11):1097-1099 - PubMed
  33. Cancer. 2012 Nov 1;118(21):5374-83 - PubMed
  34. J Med Libr Assoc. 2016 Jul;104(3):240-3 - PubMed
  35. Ann Intern Med. 2018 Dec 18;169(12):890-892 - PubMed
  36. Stat Med. 2006 Oct 30;25(20):3443-57 - PubMed
  37. J Thorac Oncol. 2006 Jul;1(6):577-9 - PubMed
  38. Am J Epidemiol. 1989 Apr;129(4):703-11 - PubMed
  39. Urology. 2006 Jan;67(1):100-4 - PubMed
  40. J Oral Pathol Med. 2004 Oct;33(9):525-32 - PubMed
  41. J Natl Cancer Inst. 1998 Aug 19;90(16):1198-205 - PubMed
  42. J Natl Cancer Inst. 1993 Jan 6;85(1):19-24 - PubMed
  43. MMWR Surveill Summ. 2016 Sep 02;65(11):1-28 - PubMed
  44. Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1071-8 - PubMed
  45. Addiction. 2008 Oct;103(10):1671-7 - PubMed
  46. Urology. 2015 Feb;85(2):388-92 - PubMed
  47. Eur Respir J. 2008 Feb;31(2):280-6 - PubMed
  48. Biomed Res Int. 2018 Dec 4;2018:1691428 - PubMed
  49. Cancer Causes Control. 2013 Oct;24(10):1811-20 - PubMed
  50. Science. 2017 Nov 17;358(6365):941-946 - PubMed
  51. Cancer Prev Res (Phila). 2009 Aug;2(8):759-68 - PubMed
  52. Cancer Causes Control. 1997 Sep;8(5):722-8 - PubMed
  53. Stat Med. 2001 Dec 30;20(24):3875-89 - PubMed
  54. J Clin Pharmacol. 2002 Nov;42(S1):71S-81S - PubMed
  55. Am J Respir Cell Mol Biol. 1999 Jun;20(6):1286-93 - PubMed
  56. JAMA Intern Med. 2016 Dec 1;176(12):1792-1798 - PubMed
  57. Pharmacol Biochem Behav. 1991 Nov;40(3):657-61 - PubMed
  58. Sci Signal. 2010 Apr 27;3(119):ra31 - PubMed
  59. Br J Cancer. 2009 Oct 6;101(7):1207-12 - PubMed
  60. BMC Cancer. 2015 Nov 11;15:897 - PubMed
  61. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):928-37 - PubMed
  62. Cancer. 2009 Mar 15;115(6):1215-23 - PubMed

MeSH terms

Publication Types

Grant support